Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q1 2026 Earnings

22FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.1

-0.94

-0.79

-0.63

Details

Expected EPS

-0.964138

Actual EPS

-0.93

Surprise EPS

0.03

Surprise Percent

+3.54%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.93 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.